Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (44)
Jingjing Xu, Xiaochen Huang, Yujie Guo, Xiaojun Ma, Pengfei Li, Shaobo Zhou, Chi Zhang, Rui Chen, Nicholas Van Halm‐Lutterodt & Linhong Yuan. (2022)
Discrepant modulating effects of dietary docosahexaenoic acid on cerebral lipids, fatty acid transporter expression and soluble beta‐amyloid levels in ApoE
−/−
and C57BL/6J mice
. Neuropathology and Applied Neurobiology 49:1.
Crossref
Crossref
Jakob L. Schroevers, Esmé Eggink, Marieke P. Hoevenaar-Blom, Jan Willem Van Dalen, Tessa Van Middelaar, Willem A. Van Gool, Edo Richard & Eric P. Moll Van Charante. (2023) Antihypertensive medication classes and the risk of dementia over a decade of follow-up. Journal of Hypertension 41:2, pages 262-270.
Crossref
Crossref
Whitney Wharton, Andrea Anderson, Kathleen M. Hayden, Owen T Carmichael, Jeanne M Clark, José A. Luchsinger, Mark Espeland & Sevil Yasar. (2022)
Effect of renin‐angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look
AHEAD
) trial
. Diabetes, Obesity and Metabolism 24:12, pages 2443-2453.
Crossref
Crossref
Xianglian Meng, Qingpeng Wei, Li Meng, Junlong Liu, Yue Wu & Wenjie Liu. (2022) Feature Fusion and Detection in Alzheimer’s Disease Using a Novel Genetic Multi-Kernel SVM Based on MRI Imaging and Gene Data. Genes 13:5, pages 837.
Crossref
Crossref
Daniel H. BaronOlivia A. SkrobotJennifer C. PalmerKanchan SharmaPatrick G. Kehoe. (2022) Renin Angiotensin System as a Potential Treatment Target for Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Journal of Neurotrauma 39:7-8, pages 473-486.
Crossref
Crossref
Ayse Basak Engin, Evren Doruk Engin & Atilla Engin. (2021) Current opinion in neurological manifestations of SARS-CoV-2 infection. Current Opinion in Toxicology 25, pages 49-56.
Crossref
Crossref
Sevil Yasar, Kyle D. Moored, Atif Adam, Fiona Zabel, Yi-Fang Chuang, Vijay R. Varma & Michelle C. Carlson. (2020) Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults. Journal of Alzheimer's Disease 75:2, pages 521-529.
Crossref
Crossref
Lucas A. C. Souza, Fatima Trebak, Veena Kumar, Ryousuke Satou, Patrick G. Kehoe, Wei Yang, Whitney Wharton & Yumei Feng Earley. (2020) Elevated cerebrospinal fluid sodium in hypertensive human subjects with a family history of Alzheimer’s disease. Physiological Genomics 52:3, pages 133-142.
Crossref
Crossref
Noha F. Abdelkader, Aya M. Abd El-Latif & Mahmoud M. Khattab. (2020) Telmisartan/17β-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer's disease: Modulation of ACE1/ACE2 and AT1/AT2 ratio. Life Sciences 245, pages 117388.
Crossref
Crossref
Charles E. Evans, James S. Miners, Giulia Piva, Christine L. Willis, David M. Heard, Emma J. Kidd, Mark A. Good & Patrick G. Kehoe. (2020) ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease. Acta Neuropathologica 139:3, pages 485-502.
Crossref
Crossref
Whitney Wharton, Liping Zhao, Kyle Steenland, Felicia C. Goldstein, Julie A. Schneider, Lisa L. Barnes, Marla Gearing & Sevil Yasar. (2019) Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives. Journal of Alzheimer's Disease 70:1, pages 153-161.
Crossref
Crossref
Esmé Eggink, Eric P. Moll van Charante, Willem A. van Gool & Edo Richard. (2019) A Population Perspective on Prevention of Dementia. Journal of Clinical Medicine 8:6, pages 834.
Crossref
Crossref
John W. Wright & Joseph W. Harding. (2019) Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer’s Disease. Journal of Alzheimer's Disease 67:2, pages 469-480.
Crossref
Crossref
Yu-Te Lin, Yi-Chung Wu, Gwo-Ching Sun, Chiu-Yi Ho, Tzyy-Yue Wong, Ching-Huang Lin, Hsin-Hung Chen, Tung-Chen Yeh, Chia-Jung Li, Ching-Jiunn Tseng & Pei-Wen Cheng. (2018) Effect of Resveratrol on Reactive Oxygen Species-Induced Cognitive Impairment in Rats with Angiotensin II-Induced Early Alzheimer’s Disease †. Journal of Clinical Medicine 7:10, pages 329.
Crossref
Crossref
Ahmed S. Kamel, Noha F. Abdelkader, Sahar S. Abd El-Rahman, Marwan Emara, Hala F. Zaki & Mahmoud M. Khattab. (2018) Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimer’s Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway. Molecular Neurobiology 55:10, pages 8188-8202.
Crossref
Crossref
Sevil Yasar, Vijay R. Varma, Gregory C. Harris & Michelle C. Carlson. (2018) Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function. Journal of Alzheimer's Disease 63:2, pages 655-664.
Crossref
Crossref
Patrick Gavin Kehoe. (2018) The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?. Journal of Alzheimer's Disease 62:3, pages 1443-1466.
Crossref
Crossref
S. Rius-Pérez, A.M. Tormos, S. Pérez & R. Taléns-Visconti. (2018) Vascular pathology: Cause or effect in Alzheimer disease?. Neurología (English Edition) 33:2, pages 112-120.
Crossref
Crossref
S. Rius-Pérez, A.M. Tormos, S. Pérez & R. Taléns-Visconti. (2018) Patología vascular: ¿causa o efecto en la enfermedad de Alzheimer?. Neurología 33:2, pages 112-120.
Crossref
Crossref
Ziheng Hu, Lirong Wang, Shifan Ma, Levent Kirisci, Zhiwei Feng, Ying Xue, William E. Klunk, M. Ilyas Kamboh, Robert A. Sweet, James Becker, Qianzhou Lv, Oscar L. Lopez & Xiang‐Qun Xie. (2018) Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4:1, pages 542-555.
Crossref
Crossref
William James Deardorff & George T. Grossberg. 2018. Clinical Psychopharmacology for Neurologists. Clinical Psychopharmacology for Neurologists
151
180
.
Whitney Wharton, Felicia C. Goldstein, Malú G. Tansey, Alexandra L. Brown, Sonum D. Tharwani, Danielle D. Verble, Amarallys Cintron & Patrick G. Kehoe. (2017) Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer’s (HEART) Trial. Journal of Alzheimer's Disease 61:2, pages 815-824.
Crossref
Crossref
Patrick Gavin Kehoe, Elliott Hibbs, Laura E. Palmer & J. Scott Miners. (2017) Angiotensin-III is Increased in Alzheimer’s Disease in Association with Amyloid-β and Tau Pathology. Journal of Alzheimer's Disease 58:1, pages 203-214.
Crossref
Crossref
Mortimer Mamelak. (2017) Energy and the Alzheimer brain. Neuroscience & Biobehavioral Reviews 75, pages 297-313.
Crossref
Crossref
Yasaman Arjmand Abbassi, Mohammad Taghi Mohammadi, Mahsa Sarami Foroshani & Javad Raouf Sarshoori. (2016) Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat. Advanced Pharmaceutical Bulletin 6:4, pages 531-539.
Crossref
Crossref
Patrick Gavin Kehoe, Steffenny Wong, Noura AL Mulhim, Laura Elyse Palmer & J. Scott Miners. (2016) Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology. Alzheimer's Research & Therapy 8:1.
Crossref
Crossref
Abdel G. Elkahloun, Roman Hafko & Juan M. Saavedra. (2016) An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease. Alzheimer's Research & Therapy 8:1.
Crossref
Crossref
Saeid Taheri, Jin Yu, Hong Zhu & Mark S. Kindy. (2016) High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 54:3, pages 1061-1072.
Crossref
Crossref
Ruth Peters, Mattan Schuchman, Jean Peters, Michelle C. Carlson & Sevil Yasar. (2016) Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies. Current Hypertension Reports 18:8.
Crossref
Crossref
Phillip J. Tully, Olivier Hanon, Suzanne Cosh & Christophe Tzourio. (2016) Diuretic antihypertensive drugs and incident dementia risk. Journal of Hypertension 34:6, pages 1027-1035.
Crossref
Crossref
Seth Love & J. Scott Miners. (2015) Cerebrovascular disease in ageing and Alzheimer’s disease. Acta Neuropathologica 131:5, pages 645-658.
Crossref
Crossref
Edith Hamel, Jessika Royea, Brice Ongali & Xin-Kang Tong. (2016) Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy. Cellular and Molecular Neurobiology 36:2, pages 219-232.
Crossref
Crossref
Emma L. Ashby, James S. Miners, Patrick G. Kehoe & Seth Love. (2016) Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex. Journal of Alzheimer's Disease 50:4, pages 1191-1203.
Crossref
Crossref
Jun Wang, Lan Tan & Jin-tai Yu. (2016) Prevention Trials in Alzheimer’s Disease: Current Status and Future Perspectives. Journal of Alzheimer's Disease 50:4, pages 927-945.
Crossref
Crossref
Daniel A. Nation, Jean Ho & Belinda Yew. (2016) Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention. Journal of Alzheimer's Disease 50:3, pages 779-789.
Crossref
Crossref
Sandrine Andrieu, Nicola Coley, Simon Lovestone, Paul S Aisen & Bruno Vellas. (2015) Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions. The Lancet Neurology 14:9, pages 926-944.
Crossref
Crossref
Nicola Coley, Adeline Gallini & Sandrine Andrieu. (2015) Prevention Studies in Alzheimer’s Disease: Progress Towards the Development of New Therapeutics. CNS Drugs 29:7, pages 519-528.
Crossref
Crossref
R. Ye, Y. Hu, A. Yao, Y. Yang, Y. Shi, Y. Jiang & J. Zhang. (2015) Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis. International Journal of Clinical Practice 69:6, pages 674-681.
Crossref
Crossref
John W. Wright, Leen H. Kawas & Joseph W. Harding. (2015) The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology 125, pages 26-46.
Crossref
Crossref
James David Cotter, Simon N Thornton, Jason KW Lee & Paul B Laursen. (2014) Are we being drowned in hydration advice? Thirsty for more?. Extreme Physiology & Medicine 3:1.
Crossref
Crossref
J. Scott Miners, Jennifer C. Palmer, Hannah Tayler, Laura E. Palmer, Emma Ashby, Patrick G. Kehoe & Seth Love. (2014) Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes. Frontiers in Aging Neuroscience 6.
Crossref
Crossref
Pavla Cermakova, Seyed-Mohammad Fereshtehnejad, Kristina Johnell, Bengt Winblad, Maria Eriksdotter & Dorota Religa. (2014) Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. Alzheimer's Research & Therapy 6:3, pages 34.
Crossref
Crossref
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado & Juan C. Carril. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
323
556
.
Rónán O’CaoimhPatrick Gavin Kehoe, Paul Kennedy & William Molloy. (2013) Use of angiotensin-converting enzyme inhibitors for Alzheimer’s disease: an update. Neurodegenerative Disease Management 3:6, pages 511-514.
Crossref
Crossref